BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. (2024). Bangladesh Journal of Medicine, 35(20), 165. https://doi.org/10.3329/bjm.v35i20.73432